top of page

Leadership

Dr. Ethan Shen

Chairman & CEO

Dr. Ethan Shen is a visionary entrepreneur and academic leader dedicated to transforming global healthcare through innovation and excellence. With over two decades of experience in biotechnology, translational medicine, and leadership, Dr. Shen has established a reputation as a pioneer in the field.

"At YD Biopharma, we believe in the power of science to create a healthier tomorrow. Together, we can redefine the future of healthcare and bring life-changing solutions to those who need them most"

Benjamin Zhang, MD

Chief Medical Officer (CMO)

Dr. Benjamin Zhang is a pioneering leader in cancer immunotherapy and regenerative medicine, with significant expertise in immune cell research, stem cell therapy, and clinical trial management. As the Chief Medical Officer at YD Biopharma, Dr. Zhang drives the company’s cutting-edge efforts in gamma delta T cell expansion and exosome therapy for cancer treatment. He also serves as the CMO of JY Biomedical, where he oversees clinical operations and the development of advanced cancer therapies.

At YD Biopharma, we are committed to translating cutting-edge research into tangible benefits for patients. By fostering innovation and collaboration, we strive to shape the future of cancer care and regenerative medicine, bringing hope to those in need.

Mr. Edmund Hen

Chief Financial Officer (CFO)

Mr. Edmund Hen is a seasoned financial expert with over two decades of experience in corporate finance, capital markets, and business strategy. As the Chief Financial Officer (CFO) at YD Biopharma, he brings extensive knowledge of financial management, regulatory compliance, and business development. His leadership has been instrumental in guiding the company through significant growth and market expansion.

At YD Biopharma, we understand the importance of sound financial management in driving sustainable growth. Through collaboration, innovation, and disciplined financial strategy, we continue to empower the company to deliver life-changing solutions to our patients and stakeholders.

May Tsai

Chief Business Officer (CBO)

May Tsai is a highly experienced leader with over two decades of expertise in supply chain management, procurement, project management, and risk management. As the Chief Business Officer (CBO) at YD Biopharma, she brings a wealth of knowledge in driving business strategies, operational excellence, and enhancing stakeholder relationships to support the company’s growth and global expansion.

At YD Biopharma, we are dedicated to advancing the future of healthcare through innovation, operational efficiency, and strategic business development. Together, we are creating solutions that will transform the industry and improve lives.

bottom of page